Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Cells
Hannah K DrescherRalf Weiskirchen

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries with almost 25% affected adults worldwide. The growing public health burden is getting evident when considering that NAFLD-related liver transplantations are predicted to almost double within the next 20 years. Typically, hepatic alterations start with simple steatosis, which easily progresses to more advanced stages such as nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. This course of disease finally leads to end-stage liver disease such as hepatocellular carcinoma, which is associated with increased morbidity and mortality. Although clinical trials show promising results, there is actually no pharmacological agent approved to treat NASH. Another important problem associated with NASH is that presently the liver biopsy is still the gold standard in diagnosis and for disease staging and grading. Because of its invasiveness, this technique is not well accepted by patients and the method is prone to sampling error. Therefore, an urgent need exists to find reliable, accurate and noninvasive biomarkers discriminating between different disease stages or to develop innovative imaging techniques to quantify steatosis.

References

Oct 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D Byron, G Y Minuk
May 7, 2002·IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control·Laurent SandrinMathias Fink
May 14, 2004·IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control·Jérémy BercoffMathias Fink
Dec 4, 2004·Gastroenterology·William M C RosenbergUNKNOWN European Liver Fibrosis Group
Feb 23, 2005·Expert Review of Molecular Diagnostics·Thierry PoynardVlad Ratziu
May 27, 2005·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·V N Dos SantosE R Parise
Jun 9, 2005·Gastroenterology·Vlad RatziuUNKNOWN LIDO Study Group
Dec 1, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul CalèsFrançoise Lunel
Apr 11, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Janardan K Reddy, M Sambasiva Rao
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard K SterlingUNKNOWN APRICOT Clinical Investigators
Aug 17, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Helen LydatakisIoannis Diamantis
Mar 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul AnguloChristopher P Day
Nov 29, 2007·The American Journal of Gastroenterology·Poonam Mishra, Zobair M Younossi
Dec 18, 2007·Alimentary Pharmacology & Therapeutics·M H JarrarZ M Younossi
Apr 25, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Robert P MyersAbdel Aziz M Shaheen
Jun 16, 2009·Gastroenterology·Anna KotronenHannele Yki-Järvinen
Jul 9, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ariel E FeldsteinArthur J McCullough
Sep 22, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Jeong-Hoon LeeHyo-Suk Lee
Oct 13, 2009·Clinics in Liver Disease·Brent A Neuschwander-Tetri
Apr 22, 2010·The American Journal of Gastroenterology·Elmar AignerChristian Datz
May 25, 2010·Journal of Hepatology·Vlad RatziuGiulio Marchesini
Jul 14, 2010·European Journal of Clinical Investigation·Yusuf YilmazErol Avsar
Aug 27, 2010·BMC Gastroenterology·Giorgio BedogniClaudio Tiribelli
Dec 15, 2010·Journal of Hepatology·Tarek I Abu-Rajab TamimiAriel E Feldstein
Apr 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giliola CaloriGianluca Perseghin
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kris V KowdleyUNKNOWN NASH Clinical Research Network
May 10, 2012·Therapeutic Advances in Gastroenterology·Jacob M KneemanKathleen E Corey
Jul 11, 2012·Journal of Magnetic Resonance Imaging : JMRI·Scott B ReederClaude B Sirlin
Aug 30, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sudeep TanwarWilliam M Rosenberg
Nov 14, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Naim AlkhouriValerio Nobili
Nov 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donghee KimTerry M Therneau

❮ Previous
Next ❯

Citations

Jan 28, 2020·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Takuro NagoyaShuji Terai
Jun 24, 2020·The Annals of Pharmacotherapy·John A DoughertyKrisy-Ann Thornby
Jul 18, 2020·Diabetes/metabolism Research and Reviews·Simona Cernea, Itamar Raz
Jul 28, 2020·Expert Review of Gastroenterology & Hepatology·Antonella MoscaAnna Alisi
Dec 19, 2019·Frontiers in Immunology·Daphne van der HeideRuchi Bansal
Sep 19, 2020·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Pablo J GiraudiNatalia Rosso
Jan 16, 2021·Journal of Clinical and Translational Hepatology·Marion DuriezAnne-Céline Le Fèvre
Nov 5, 2020·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Hassan Reda Hassan ElsayedRanda El-Gamal
Feb 7, 2021·The Journal of Nutritional Biochemistry·Shu-Ju WuChian-Jiun Liou
Jun 2, 2020·Toxicology·Venkat R PannalaAnders Wallqvist
Mar 2, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Yuqi YingShuangchun Liu
May 26, 2021·Nature Communications·Ning MaDong Xie
May 25, 2021·Frontiers in Pharmacology·Pragyan AcharyaRalf Weiskirchen
Aug 1, 2021·Molecular Diagnosis & Therapy·Jesús García-FoncillasMaría Vanessa Pérez Gómez
Nov 26, 2021·Alimentary Pharmacology & Therapeutics·Mi Na KimSang Hoon Ahn

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
biopsy
biopsies
imaging technique

Software Mentioned

Hepascore
FibroSTARD
FibroSURE ActiTest
FibroTest
Liver
FibroMeter

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.